Ala. Court Nixes $78M Price Inflation Verdict Against Sandoz
The Alabama Supreme Court on Friday overturned a $78.4 million jury verdict against generic-drug maker Sandoz Inc. for charging the state's Medicaid program artificially inflated drug prices, marking the second time...To view the full article, register now.
Already a subscriber? Click here to view full article